240 related articles for article (PubMed ID: 5621697)
1. [The limitations of therapy with progestational hormones].
Alicino R; Borsò N
Quad Clin Ostet Ginecol; 1967 Dec; 22(12):1045-54. PubMed ID: 5621697
[No Abstract] [Full Text] [Related]
2. [The use of cyclofarlutal in gynecological treatments].
Albano V; Cittadini E; Quartararo P
Minerva Ginecol; 1966 Nov; 18(22):1247-52. PubMed ID: 6011796
[No Abstract] [Full Text] [Related]
3. [Ovariostatic drugs and their use in gynecologic pathology].
Vaglio N
Arch Ostet Ginecol; 1967; 72(6):693-706. PubMed ID: 4237146
[No Abstract] [Full Text] [Related]
4. Indications for therapy with progestational agents.
Darragh A
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
[No Abstract] [Full Text] [Related]
5. [Progestational hormones].
Donayre J
Rev Soc Peru Endocrinol; 1966 Jun; 3(1):79-88. PubMed ID: 5950273
[No Abstract] [Full Text] [Related]
6. [On synthetic progestational hormones in gynecologic hormonal therapy].
Corrado F; Amaturo G
Quad Clin Ostet Ginecol; 1968 Aug; 23(8):732-46. PubMed ID: 5746118
[No Abstract] [Full Text] [Related]
7. Progestational agents.
Br Med J; 1969 Aug; 3(5666):344-6. PubMed ID: 5816498
[No Abstract] [Full Text] [Related]
8. [Substitution therapy with steroid hormones in gynecology].
Lauritzen C
Dtsch Med J; 1970 Jul; 21(14):925-8 passim. PubMed ID: 5508353
[No Abstract] [Full Text] [Related]
9. [Comparative studies of the effect of various gestagens with special reference to the manifestation of rhythmic effects].
Rauscher H
Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):551-9. PubMed ID: 4251826
[No Abstract] [Full Text] [Related]
10. [Modern hormone therapy in gynecology].
Husslein H
Hippokrates; 1967 Jul; 38(13):506-13. PubMed ID: 5611579
[No Abstract] [Full Text] [Related]
11. [Gynecological indications of a new progestational agent with prolonged action].
Goisis M; Candotti G
Minerva Ginecol; 1970 Mar; 22(6):339-67. PubMed ID: 5515153
[No Abstract] [Full Text] [Related]
12. [The current status of gestagen administration. 1. Introduction, gestagens in gynecology].
Völker W
Fortschr Med; 1977 Jan; 95(1):15-9. PubMed ID: 832824
[No Abstract] [Full Text] [Related]
13. [Effects of ovarian inhibition treatment in aluteal or dysluteal states with hyperandrogenism].
Laham E
Rev Med Moyen Orient; 1967; 24(4):379-82. PubMed ID: 5269293
[No Abstract] [Full Text] [Related]
14. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
Signorelli I; Emanueli A
Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
[No Abstract] [Full Text] [Related]
15. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
Fiorino S; Rossi T; Scio A
Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
[No Abstract] [Full Text] [Related]
16. [Norsteroids in gynaecological therapy (author's transl)].
Dvorák K; Cernoch A
Cesk Gynekol; 1973 Sep; 38(8):620-1. PubMed ID: 4765141
[No Abstract] [Full Text] [Related]
17. [Use of synthetic progestational hormones in gynecologic practice].
Seroshevski Iu; Komarovska A; Legevski A
Akush Ginekol (Mosk); 1969 Oct; 45(10):27-8. PubMed ID: 5393459
[No Abstract] [Full Text] [Related]
18. [Use of the preparation dl-13-ethyl-17-alpha-ethinyl-17-beta-hydroxy-4-gonen-3-on (WY 3707) in combination with ethinyl estradiol in gynecologic treatment and contraception].
Misinger I; Krobová I; Moravcová V
Cesk Gynekol; 1968 Jun; 33(5):329-32. PubMed ID: 5662271
[No Abstract] [Full Text] [Related]
19. [Indications for the treatment with so-called ovulation inhibitors].
Haller J
Dtsch Med Wochenschr; 1966 Sep; 91(37):1653-5. PubMed ID: 5946154
[No Abstract] [Full Text] [Related]
20. [Clinical studies with synthetic gestagens].
Tóth F; Horn B; Primász P
Orv Hetil; 1969 Jul; 110(30):1723-7. PubMed ID: 5801101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
